Lactobacillus rhamnosus GG (LGG)

Probioticlactic acid bacteriaStrong dose evidence

Also known as: LGG, L. rhamnosus GG, ATCC 53103, Lacticaseibacillus rhamnosus GG, Culturelle strain

Add to a formula

LGG (Lactobacillus rhamnosus GG, ATCC 53103) is the single most studied probiotic strain, isolated in 1985 and since reclassified as Lacticaseibacillus rhamnosus. Systematic reviews and meta-analyses cover antibiotic-associated diarrhea in children and adults, acute gastroenteritis in children, and eczema risk in infants, at daily doses that usually fall between 1 and 10 billion CFU. It is used in daily gut-support, travel, and children's formulas. LGG survives gastric acid well and adheres to intestinal mucus, which is why it is often chosen as the anchor strain in a blend.

Research summary

Adheres to intestinal mucus via SpaCBA pili; studied for support of epithelial barrier function and modulation of mucosal immune signaling.

Dosage

Daily amounts, of compound. CFU shown in billions.

Lowest studiedTypical rangeHighest studiedUpper limit
1 B CFU1–10 B CFU

Amounts are in billions of CFU (enter 10 for 10 billion). Raw-material weight assumes a 100 billion CFU/g concentrate (10 mg per billion CFU); manufacturers add a 20–50% CFU overage at fill so the label claim holds through shelf life, and the label should state whether CFU are guaranteed at manufacture or at expiry. Meta-analyses note that higher daily counts (around 10 billion) performed more consistently than lower ones in antibiotic-associated diarrhea trials.

Standardization: Strain ATCC 53103 designated on CoA; CFU per gram stated

Source material: freeze-dried culture

As supplied: Assumes 100 billion CFU/g concentrate (10 mg per billion CFU); adjust to supplier CoA.

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Heat- and moisture-sensitive vegetative cells; capsule or dry powder only.

Formulation notes

The LGG name is a registered trademark of the strain owner; generic L. rhamnosus is a different ingredient. Separate from antibiotic dosing by at least two hours. Keep water activity low in the finished product.

Sources

  1. NIH ODS — Probiotics Fact Sheet for Health ProfessionalsNIH ODS
  2. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. (Szajewska 2015)PubMed
  3. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update. (Szajewska 2019)PubMed

Related ingredients